Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in CashFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Other Working Capital Changes (2021 - 2024)

Goldenwell Biotech's Other Working Capital Changes history spans 4 years, with the latest figure at -$54.0 for Q4 2024.

  • For Q4 2024, Other Working Capital Changes changed N/A year-over-year to -$54.0; the TTM value through Sep 2025 reached -$54.0, changed 0.0%, while the annual FY2024 figure was -$54.0, 99.79% up from the prior year.
  • Other Working Capital Changes reached -$54.0 in Q4 2024 per GWLL's latest filing, roughly flat from -$54.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $62586.0 in Q1 2021 to a low of -$25372.0 in Q1 2023.
  • Average Other Working Capital Changes over 4 years is $3554.2, with a median of -$3747.0 recorded in 2022.
  • Peak YoY movement for Other Working Capital Changes: plummeted 578.4% in 2023, then soared 99.79% in 2024.
  • A 4-year view of Other Working Capital Changes shows it stood at -$3690.0 in 2021, then fell by 1.73% to -$3754.0 in 2022, then crashed by 575.87% to -$25372.0 in 2023, then skyrocketed by 99.79% to -$54.0 in 2024.
  • Per Business Quant, the three most recent readings for GWLL's Other Working Capital Changes are -$54.0 (Q4 2024), -$54.0 (Q1 2024), and -$25372.0 (Q3 2023).